| |
Bangalore,
May 30’ 06: EuroCor GmBH, a wholly-owned subsidiary
of Opto Circuits (India) Ltd. (OCI), a leading manufacturer
of healthcare equipments in India, has received CE approval
for marketing and sale of Amadeus Supercross,
a coronary dilation catheter and E-WIRE,
a guide wire for interventional use. Both products are used
in Coronary Angioplasty (Percutaneous Transluminal Coronary
Angioplasty- PTCA). CE-approved Amadeus Supercross and E-WIRE
are expected to add 3-5 Million and 1 Million Euros respectively,
per year.
Highlighting the strategic importance
of this development, Vinod Ramnani, Chairman &
Managing Director, OCI, said: “The CE certification
adds a global dimension to both the products as we can now
tap almost 50% of the large US $ 8 billion PTCA market (i.e.,
stents, balloons, guidewires, guide catheters and accessories).
It is of considerable consequence in boosting revenues for
EuroCor; in the first year itself, we expect Amadeus and E-WIRE
to together to garner around 4-6 million Euros and with a
three-year perspective that translates into 189 to 325 million
Rs. for Opto.”
Coronary artery dissections and spasms are common issues during
an Angioplasty and Amadeus Supercross provides just the controlled
safety balloon compliance for less dissections & low trauma
PTCA. EuroCOR’s E-WIRE is used to guide an interventional
device (such as a balloon catheter) for restoring normal blood
flow to an obstructed vessel and its key feature is that it
removes abrupt transitions.
EuroCOR has recently received
CE approval for its blockbuster drug-eluting stent- TAXCOR,
subsequent to which the company bagged orders from Brazil
and Egypt totaling 41.8 crore.
OCIL and EuroCor GmbH have an
aggressive marketing strategy to promote its entire range
of interventional coronary stent systems and balloon dilation
catheters through already appointed and established 26 distributors
located worldwide. EuroCOR has also signed a distribution
agreement with the German/Swiss medical device sales organization
"Fumedica AG" which took overall marketing and distribution
rights of this product basket for the German and Swiss market.
About Opto Circuits
(India) Ltd.
Opto Circuits (India)
Ltd. (OCIL) (BSE Code: 532391; NSE Symbol: OPTOCIRCUI) is
a leading manufacturer of healthcare equipments in India.
The product profile includes digital thermometers, sensors,
probes, pulse oximeters, patient monitoring systems and innovative
products in the pipeline. In 2001, OCIL acquired 60% stake
in Advanced Micronic Devices to market its equipments in India.
OCIL recently completed the acquisition of EuroCor GmbH in
Germany. EuroCor manufactures Cardiac Stents of various types,
including Drug Eluting coronary Stents used in Critical Cardiac
Care. Visit us at www.optoindia.com |
|
